Pancreas after kidney transplantation: HLA mismatch does not preclude success.
Basadonna
G P
GP
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
Auersvald
L A
LA
Oliveira
S C
SC
Friedman
A L
AL
Lorber
M I
MI
D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D016559:Tacrolimus